Replacement of osteogenic cells with BMAT decreases bone quality and contributes to an overall poor metabolic environment
This improves the oxygen-efficiency of energy production and reduces infarct expansion and arrhythmic substrate

Some of the most notable similarities between Tirzepatide and Ozempic include: Most commonly administered through weekly injections Improve metabolic health Lower blood sugar and A1C FDA-approved for weight loss Have a history of treating type II diabetes Evidence of significant weight loss Synthesize GLP-1 hormones May cause nausea, stomach upset, diarrhea, and vomiting as temporary side effects Insurance coverage varies widely when prescribed only for weight loss No currently available generic version Cannot take with other GLP-1 drugs Injected in the same areas: stomach, thigh, or upper arm Injections can be self-administered at home May help improve overall health including lowering the risk of certain cardiac conditions and anything related to the patients weight It is important to note that while Ozempic and Tirzepatide are very similar, they are not interchangeable and the dosages are completely different

Throw away all opened vials after use, even if there is medicine left in the vial
Sjgrens syndrome: old and new therapeutic targets
A stratified Cox proportional hazards model was used, with treatment as a fixed effect and trial-level cardiovascular risk as the stratification factor, to estimate hazard ratios (HRs) and confidence intervals (CIs) when comparing tirzepatide to the control